4//SEC Filing
Stone Christopher Lewis 4
Accession 0000882104-17-000126
CIK 0000882104other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 8:04 PM ET
Size
4.8 KB
Accession
0000882104-17-000126
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Disposition to Issuer
Common stock
2017-12-15−17,959→ 430,787 total
Footnotes (1)
- [F1]Disposition of common stock due to performance criteria not being achieved under equity incentive plans.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeother
Related Parties
1- filerCIK 0001453373
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 8:04 PM ET
- Size
- 4.8 KB